Clinical Trial Update: Initial Treatment With Golimumab in Early PsA [Phase 3]

View source ↗

Summary

Phase 3 trial updating initial treatment with golimumab in early psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED